Home

Current Issue

Archives

Guidelines for Authors

Classified Ads

Links

Search PubMed

Subscriptions

Subscriber Registration

Guidelines for Website Users

JRheum Update Service

Contact Info

Notices

December 1-6, 2002 — APLAR 2002, Bankok, Thailand. Contact: Congress Secretariat, tel. 662 716 6524, fax 662 716 6525, E-mail: thairheum@hotmail.com; www.aplar2002.com

2003

February 24-28, 2003 — 11th Intensive Applied Epidemiology Course for Rheumatologists, Manchester, UK. Contact: L. McClair, ARC Epidemiology Unit, University of Manchester, Oxford Road, Manchester, M13 9PT. UK. Tel. 44 161 275 5993, fax 44 161 275 5043, E-mail: lisa@fs1.ser.man.ac.uk

March 28-29, 2003 — Advances in Anatomy and Clinical Examination of the Hand, Brussels, Belgium. Contact: Dr. F. Schuind, Department of Orthopaedics, Erasme University Hospital, 808 route de Lennik, B-1070 Brussels, Belgium. Tel. 32 2555 6844, fax 32 2520 3556. E-mail: Hand.congress@ulb.ac.be

June 18-21, 2003 — EULAR 2003, Annual European Congress of Rheumatology, Lisbon, Portugal. www.eular.org.

October 23-28, 2003 — 67th Annual American College of Rheumatology Meeting, Orlando, Florida, USA. Contact: American College of Rheumatology, Suite 250, 1800 Century Place, Atlanta, Georgia 30345-4300. www.rheumatology.org.

Eleventh Intensive Applied Epidemiology Course for Rheumatologists
February 24-28, 2003, Manchester, UK
Presented by the ARC Epidemiology Unit, University of Manchester. The course is residential and is limited to 25 places.
For information contact L. McClair, ARC Epidemiology Unit, University of Manchester, Oxford Road, Manchester M13 9PT, UK. Tel. 44 0161 275 5993, fax 44 0161 275 5043. E-mail: lisa@fs1.ser.man.ac.uk

WEGENER'S GRANULOMATOSIS ETANERCEPT TRIAL
A multicenter, randomized trial of etanercept (combined with conventional treatment) versus placebo (combined with conventional treatment). WGET is funded jointly by the National Institute of Arthritis, Musculoskeletal, and Skin Diseases and the Food & Drug Administration's Office of Orphan Products Development. Experimental medication (etanercept/placebo) provided for patients enrolled. For information regarding patient referral to one of the eight clinical centers in the United States, please contact either: John H. Stone, MD, MPH, The Johns Hopkins University Vasculitis Center, tel 410-614-4905, or Gary S. Hoffman, MD, The Center for Vasculitis Care and Research, Cleveland Clinic Foundation, tel 216-445-6996.